Stock Updates

Today’s Top Gainers in the Market Bristol-Myers Squibb Company (NYSE:BMY) from Healthcare

Today’s top gainers include the company Bristol-Myers Squibb Company (NYSE:BMY) which is in the industry Drug Manufacturers – Major, gaining -0.56% today. In the last week its performance is -19.05%, and -14.01% for the past quarter. Currently, Bristol-Myers Squibb Company, BMY has a target price of 77.5, so today’s gain of -0.56% is a significant step towards its target price. The GAP today is therefore 0.43%.

Bristol-Myers Squibb Company (NYSE:BMY), has a market cap of 101819.9, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 74.70%.

At the current price of 60.63, it has a dividend yield of 2.49%, and its target price is 77.5. This is with a profit margin of 16.30%, and total debt/equity of 0.45. Bristol-Myers Squibb Company (NYSE:BMY) has a P/E of 35.68, as well as a forward P/E of 18.63.

With a current EPS of 1.71, and a forecasted EPS growth for next year at 24.08%,Bristol-Myers Squibb Company (NYSE:BMY) has had a EPS growth for the past five years at -12.20%. For the next five years EPS growth is projected to be 23.45%.

Performance for the year is 0.00%. Since its IPO date on 6/1/1972, the total performance to date is -10.37%.

Volume today for Bristol-Myers Squibb Company (NYSE:BMY), is 9371750, while its average volume is 8279.64. Whilst the total gain today was -0.56%, it did have a day high of -21.38%.

Volatility for this week has been at 3.55%, and 1.96% for the month. The 52-week low for Bristol-Myers Squibb Company, BMY has been 19.72%, while the 52-week-high has reached -21.38%.

Looking at its return of investments, which is 4.60%, and its return on assets is 9.00%. Bristol-Myers Squibb Company (NYSE:BMY) has an operating margin of 20.80%. With a sales growth of 17.00% quarter over quarter. Bearing in mind that Bristol-Myers Squibb Company, BMY is in the sector Healthcare, its long-term debt/equity is 0.44, and has a current ratio of 1.6 and 1.4 for quick ratio.

So what is the value of Bristol-Myers Squibb Company? Well its PEG is 1.52, and the P/S is 5.78, along with a P/B of 6.83. Meanwhile it has a p/cash of 21.89.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment